Brexit blamed as UK car production plummets 44.5% in April

IMechE | May 30, 2019

Brexit blamed as UK car production plummets 44.5% in April
Car production fell for the 11th consecutive month in April, with 44.5% fewer cars built than in the same month last year. The Society of Motor Manufacturers and Traders, which released the figures, said Brexit was to blame. Companies brought forward and extended factory shutdowns – usually scheduled for the summer holiday – to mitigate against the expected uncertainty of leaving the European Union on 29 March. The SMMT urgently called for the government to take a no deal Brexit off the table, saying ongoing instability was having a devastating impact on the UK’s automotive sector. The frontrunners in the Conservative leadership race to become the next Prime Minister, Boris Johnson and Dominic Raab, have both kept the option open however. Today’s figures are evidence of the vast cost and upheaval Brexit uncertainty has already wrought on UK automotive manufacturing businesses and workers, said SMMT chief executive Mike Hawes.

Spotlight

Ready or not, the next generation of manufacturing has arrived. Manufacturers are up against coalescing forces of technological disruption, economic uncertainty, globalization, and trade upheaval-all of which will shape the manufacturing industry of tomorrow.

Related News

Sandoz and Austrian Government JV to Strengthen European Antibiotics Manufacturing

Sandoz | July 27, 2020

Sandoz, the Novartis generics and biosimilars division, is pleased to announce plans for a joint investment, together with the Austrian federal government, to strengthen the long-term future of integrated antibiotics manufacturing in Europe. Sandoz CEO Richard Saynor said: “This plan is a great example of government and the private sector working closely together to protect the long-term interests of patients in Europe and beyond. Antibiotics are the backbone of modern medicine and our Kundl facility in Austria is the hub and center of the last remaining integrated production chain for antibiotics in the western world. This joint investment will help to keep it that way.” Sandoz intends to invest more than EUR 150 million over the next five years to strengthen the long-term competitiveness of its integrated antibiotic manufacturing operations at Kundl, developing and introducing innovative manufacturing technology for both active pharmaceutical ingredients (APIs) and finished dosage forms (FDFs).

Read More

iBASEt Announces Improved Manufacturing Intelligence Application for Intelligent Decision Support

iBASEt | May 19, 2020

iBASEt, today announced the general availability of an improved Manufacturing Intelligence application. The company's Manufacturing Intelligence application now provides a faster comparison of real-time and historical activity to unlock future performance gains. As a value-added application in iBASEt's Digital Operations Suite, Manufacturing Intelligence provides out-of-the-box analytical capabilities with comprehensive reporting. iBASEt, a leading provider of manufacturing, quality and MRO solutions that enable digital continuity, today announced the general availability of an improved Manufacturing Intelligence application. iBASEt customers upgrading to this enhanced product can increase process efficiency, drive intelligent decision support, and achieve higher quality standards. In today's digital environments where data is collected at an accelerating pace, manufacturers are challenged with how to best analyze and act upon this wealth of knowledge. As part of iBASEt's continued focus on simplifying the complex, the company's Manufacturing Intelligence application now provides a faster comparison of real-time and historical activity to unlock future performance gains. Read more: Atos and Siemens Introduce 'Process Digital Twin' Solution for Pharma Manufacturing As a value-added application in iBASEt's Digital Operations Suite, Manufacturing Intelligence provides out-of-the-box analytical capabilities with comprehensive reporting, a data warehouse, Extract, Transfer and Load (ETL) scripts, and pre-configured dashboards for manufacturers using iBASEt's Solumina. Manufacturing Intelligence now provides greater contextual visibility into operations processes to help drive decisions and streamline production, quality, and MRO workflows, improving overall efficiency and quality performance. We continue to invest in adding functionality across our product suite. Manufacturing Intelligence now provides more value to our customers with real-time, contextual measurement capabilities and more useful dashboards, ideal for frontline workers, supervisors and managers. - John Fishell, Vice President, Product Development at iBASEt "Manufacturing Intelligence is an ideal complement for customers leveraging the iBASEt Digital Operations Suite and can be provided at a fraction of the cost of an internally built solution." Read more: Can OT Learn From IT? About iBASEt: iBASEt is a leading provider of manufacturing, quality and MRO solutions that enable digital continuity across the enterprise. With 30+ years of experience in highly engineered, regulated industries, iBASEt simplifies the complex by empowering customers to gain real-time visibility, take control, and drive velocity across their operations and extended value chain. iBASEt works closely with industry leaders, including Lockheed Martin, Northrop Grumman, Rolls Royce, Pratt & Whitney, and Patricia Belgian Engine Center.

Read More

MANUFACTURING TECHNOLOGY

Platinum Equity Announces Sale Of Singapore-Based Electronics Manufacturing Services Provider PCI To Celestica

Platinum Equity | September 22, 2021

Platinum Equity announced today the signing of a definitive agreement to sell PCI Limited ("PCI"), an electronics manufacturing services provider based in Singapore, to Celestica Inc. (TSX: CLS) (NYSE: CLS), headquartered in Toronto, a leader in design, manufacturing and supply chain solutions for the world's most innovative companies, for $306 million in cash. The sale is expected to close in mid-fourth quarter of 2021, subject to regulatory approval and customary closing conditions. PCI is a fully integrated design, engineering and manufacturing solutions provider with six manufacturing and design facilities across Asia. The business serves diverse end-markets, including the automotive, industrial equipment, commercial, consumer/lifestyle, and medical segments. Platinum Equity, a Los Angeles-based global private equity firm focused on acquiring businesses that can benefit from the firm's operational expertise, acquired PCI in April 2019 in a public-to-private transaction. The PCI investment was led by Platinum Equity's Singapore office. "We have committed substantial financial, M&A and operational resources to our investment strategy in Asia and PCI's success is yet another example of how we are creating value in the region," said Jacob Kotzubei, the partner in Platinum Equity's Los Angeles headquarters who oversees the firm's Singapore-based team. "We have deep experience transacting in Asia and a dedicated team on the ground that has real momentum." The PCI sale will mark Platinum Equity's second divestiture in Singapore in the past year, having sold Singapore-based Compart Systems to Shanghai Wayne Enterprises in December 2020. "By partnering with PCI's leadership team, we accelerated the company's transformation into a technology-driven enterprise that is integral to its customers' product development and supply chain ecosystems," said Soo Jin Goh, Managing Director at Platinum Equity and head of the firm's Singapore-based investment team. "We invested in people and systems, transformed the company's sales organization and go-to-market approach to accelerate growth, and initiated 'smart factory' automation projects to increase efficiencies and create operating leverage as the company continues to scale." Since Platinum Equity's acquisition of PCI, the company grew annual revenue by more than 40% and substantially improved its profitability. PCI also doubled its pace of customer acquisition during that time, with an emphasis on meeting the increased demand for connected products and devices. This resulted in a substantial contract win in June 2021 to manufacture a wearable contact tracing device as part of the Singapore government's efforts to stop the spread of Covid-19. "Under Platinum Equity's ownership, we have accelerated our transformation on many fronts, investing in machinery and system upgrades, adding new talent to our organization, and setting the stage for a new period of growth and expansion," said PCI CEO EL Teo. "Celestica is an industry leader, and the ideal home for our business going forward. We are excited to leverage Celestica's global footprint and significant resources to rapidly expand our business and introduce our solutions to more customers around the world." "The acquisition of PCI will enable us to build on our transformation initiatives and expand our portfolio with innovative capabilities in key growth markets," said Rob Mionis, President and CEO, Celestica. "PCI has built one of the premier teams in the industry and a differentiated set of capabilities that make them a true value-added partner to their customers. By combining our portfolios and innovation platforms, we will be able to capitalize on emerging industry trends and strengthen our offerings to customers in order to generate significant value for all Celestica shareholders." Lincoln International is serving as financial advisor to Platinum Equity on the sale of PCI. BDA Partners is providing advisory services to Platinum Equity in Asia. Duane Morris is serving as Platinum Equity's legal advisor on the transaction. About Platinum Equity Founded in 1995 by Tom Gores, Platinum Equity is a global investment firm with more than $25 billion of assets under management and a portfolio of approximately 50 operating companies that serve customers around the world. The firm is currently investing from Platinum Equity Capital Partners V, a $10 billion global buyout fund, and Platinum Equity Small Cap Fund, a $1.5 billion buyout fund focused on investment opportunities in the lower middle market. Platinum Equity specializes in mergers, acquisitions and operations – a trademarked strategy it calls M&A&O® – acquiring and operating companies in a broad range of business markets, including manufacturing, distribution, transportation and logistics, equipment rental, metals services, media and entertainment, technology, telecommunications and other industries. Over the past 25 years Platinum Equity has completed more than 300 acquisitions.

Read More

Spotlight

Ready or not, the next generation of manufacturing has arrived. Manufacturers are up against coalescing forces of technological disruption, economic uncertainty, globalization, and trade upheaval-all of which will shape the manufacturing industry of tomorrow.